BLACKLEDGER Selling Watch: ABOS, CCJ, AVAX
BLACKLEDGER's latest selling watch update tracks ABOS, CCJ, AVAX, DOT, PLUG, TIA from the active public watchlist. This post is built from public-safe status data, in-house public signal labels, and outside public source context. It is designed to help readers understand what is happening around each asset without exposing private research methods.
Selling Watch Data
The dedicated feed category for this update is Selling. The latest public scan timestamp is 2026-06-26T08:00:56.297573+00:00.
- ABOS (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- CCJ (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- AVAX (crypto): Bear public bias, Extended, public score 8.3/10, status: Paper trading research.
- DOT (crypto): Bear public bias, Extended, public score 8.3/10, status: Paper trading research.
- PLUG (stock): Bear public bias, Extended, public score 8.3/10, status: Paper trading research.
- TIA (crypto): Bear public bias, Extended, public score 8.3/10, status: Paper trading research.
- AUD/USD (forex): Bear public bias, Extended, public score 8.3/10, status: Paper trading research.
- IQ (stock): Bear public bias, Extended, public score 8.0/10, status: Paper trading research.
Educational Context: How To Use This Page
This page is not a trade instruction. It is an educational research brief. Readers can use it to understand company or project background, public market context, public status labels, and relevant outside-source headlines before doing their own due diligence.
ABOS Public Research Bio
Name: Acumen Pharmaceuticals, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is in its Phase 2 ALTITUDE-AD clinical trial to target toxic soluble amyloid beta oligomers. Acumen Pharmaceuticals, Inc. has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug, as well as with JCR Pharmaceuticals Co. Ltd for the development of Aß oligomer-targeted enhanced brain delivery therapy for the treatment of Alzheimer's disease. The company was incorporated in 1996 and is headquartered in Newton, Massachusetts.
- Latest public price/reference: $2.205
- Public market capitalization: $159.62M
- Recent public volume/reference: 376.91K
- One-month public movement: -2.22%
- Sector/category: Healthcare
Why ABOS Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Acumen Nominates 2 Therapies to Treat Alzheimer’s Disease — Exec Edge
- Acumen Pharmaceuticals Inc (ABOS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... — GuruFocus.com
- Acumen Pharmaceuticals Q1 Earnings Call Highlights — MarketBeat
- Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner — Zacks
CCJ Public Research Bio
Name: Cameco Corporation. Market class: stock. Public bias: Bear. Public tier: Extended.
Cameco Corporation provides uranium for the generation of electricity in the Americas, Europe, and Asia. It operates in three segments: Uranium, Fuel Services, and Westinghouse. The Uranium segment engages in the exploration for, mining, milling, purchase, and sale of uranium concentrate. Its Fuel Services segment is involved in the refining, conve[redacted]on, and fabrication of uranium concentrate, as well as purchase and sale of conve[redacted]on services. The Westinghouse segment operates as a nuclear reactor technology original equipment manufacturer and a provider of products and services to commercial utilities and government agencies. It also provides outage and maintenance, engineering support, instrumentation and controls equipment, and plant modification services, as well as components and parts to nuclear reactors. The company sells its uranium and fuel products and services to nuclear utilities. Cameco Corporation was incor
- Latest public price/reference: $103.6
- Public market capitalization: $45.11B
- Recent public volume/reference: 2.97M
- One-month public movement: 7.93%
- Sector/category: Energy
Why CCJ Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Canada's nuclear push: Can it move fast enough? — Financial Post
- The U.S. Government is Supercharging the Nuclear Energy Resurgence With $17.5 Billion in Loans. Here's What it Means for Utility Stocks. — Motley Fool
- Strathmore Plus Uranium Planning a Drill Program on Beaver Rim Project — MT Newswires
- Washington Is Willing to Get Down With the Nuclear Program — Moby
AVAX Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Avalanche USD. Market class: crypto. Public bias: Bear. Public tier: Extended.
Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 463,441,061.1772119 with 431,771,961.1772119 in circulation. The last known price of Avalanche is 6.08501558 USD and is down -7.23 over the last 24 hours. It is currently trading on 1097 active market(s) with $340,272,521.68 traded over the last 24 hours. More information can be found at https://avax.network/.
- Latest public price/reference: $6.29
- Public market capitalization: $2.72B
- Recent public volume/reference: 339.54M
- One-month public movement: -8.71%
- Sector/category: not available
Why AVAX Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- MXNB Lands on Ripple XRPL Permissioned DEX to Power USD/MXN Settlement Rail — Coinspeaker
- FIFA World Cup Push Lifts Avalanche Adoption: Will AVAX Price Rally? — BeInCrypto
- Is Avalanche About to Have Its Biggest Year Yet? — Motley Fool
- AVAX Price Prediction: Treasury Stock Tumbles 38% on Nasdaq Debut as Crypto Proxy Trade Unravels — Cryptonews
DOT Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Polkadot USD. Market class: crypto. Public bias: Bear. Public tier: Extended.
Polkadot (DOT) is a cryptocurrency . Polkadot has a current supply of 1,680,239,148.70978386. The last known price of Polkadot is 1.27519617 USD and is up 0.85 over the last 24 hours. It is currently trading on 1039 active market(s) with $18,113,684,327.40 traded over the last 24 hours. More information can be found at https://polkadot.com.
- Latest public price/reference: $0.844
- Public market capitalization: $1.42B
- Recent public volume/reference: 107.67M
- One-month public movement: -17.09%
- Sector/category: not available
Why DOT Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- DOT Is Repeating XRP’s June Sentiment Crash — Except for One Crucial Catch — BeInCrypto
- Kalshi Files for XRP, XLM, SOL, SHIB, HBAR, DOGE, & 6 Other Altcoins Perp Futures — CoinGape
- Kalshi Eyes Perpetual Futures for XRP, Solana, Dogecoin—And These Altcoins — decrypt
- Is It Too Late to Buy Polkadot? — Motley Fool
PLUG Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Plug Power Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Plug Power Inc. designs, develops, and sells hydrogen products and solutions in Europe, Australia, North America, and internationally. The company offers GenDrive, a hydrogen fueled PEM fuel cell system, which powers material handling EVs, including Class 1, 2, 3 and 6 electric forklifts, automated guided vehicles, and ground support equipment; GenFuel, a liquid hydrogen fueling, delivery, generation, storage, and dispensing system; and GenCare, an Internet of Things based maintenance and on-site service program. It also provides GenKey, a turn-key solution; GenEco electrolyzers for clean hydrogen production; liquefaction systems; cryogenic equipment, such as trailers and mobile storage equipment for the distribution of liquified hydrogen, oxygen, argon, nitrogen, and other cryogenic gases; GenSure, a stationary fuel cell solution; and liquid hydrogen. The company serves customers in material handling operations, fuel cell electric vehi
- Latest public price/reference: $2.565
- Public market capitalization: $3.59B
- Recent public volume/reference: 46.41M
- One-month public movement: -9.52%
- Sector/category: Industrials
Why PLUG Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Where Will Plug Power Stock Be in 10 Years? — Motley Fool
- FuelCell Energy Drops 10%, Bloom Energy Falls 7% in a Profit-Taking Reversal as Plug Power Edges Up — 24/7 Wall St.
- FuelCell Energy Is Up 14% Today: Is It Outperforming Other Fuel Cell Stocks Like Plug Power and Bloom Energy? — 24/7 Wall St.
- Plug Power Completes Electrolyzer Deployment at Danish Green Hydrogen Facility (PLUG) — InvestorsHub
TIA Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Celestia USD. Market class: crypto. Public bias: Bear. Public tier: Extended.
Celestia (TIA) is a cryptocurrency launched in 2023and operates on the Osmosis platform. Celestia has a current supply of 1,168,685,161.483695 with 919,932,996.62251 in circulation. The last known price of Celestia is 0.34913277 USD and is down -8.05 over the last 24 hours. It is currently trading on 356 active market(s) with $39,100,146.51 traded over the last 24 hours. More information can be found at https://www.celestia.org.
- Latest public price/reference: $0.3638
- Public market capitalization: $335.58M
- Recent public volume/reference: 39.23M
- One-month public movement: -9.28%
- Sector/category: not available
Why TIA Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Leap Wallet Shutdown Forces Mass Cosmos Migration: Users Race Against the Clock — BeInCrypto
- Binance Labs-backed project shuts down operations — TheStreet
- Worst Performing Altcoins of 2025: What Went Wrong — Coinspeaker
- Celestia Ecosystem Begins to Crumble: TIA Price Prediction as Astria Network Shuttered — 99bitcoins
What The Public Data Shows
The public feed highlights ticker status, market class, directional bias, score, tier, confidence, company or project profile, public market references, and outside-source headlines. These fields support a deeper view of BLACKLEDGER's public research feed while keeping private methods undisclosed.
Why This Category Matters
The Selling section gives readers a focused path through the market: buying watch content for constructive candidates, selling watch content for defensive movement, investing content for higher-quality public watch names, and market trend notes for broader context.
Research-Only Notice
BLACKLEDGER content is market research only. There is no live execution signal, no recommendation to buy or sell, and no financial advice. Readers should perform their own due diligence and consult licensed professionals before making financial decisions.
Research-only. No execution signal. Not financial advice.